RSPH: One Of The Few Equal Weight ETFs I Follow Closely

RSPH's valuation gap versus market weight peers has narrowed but not closed, with expected returns now roughly similar to XLV. RSPH's mid-cap tilt could in my opinion benefit more than XLV from falling financing costs if the Fed moves toward rate normalization. Annualized volatility for RSPH sits at 15.67%, close to XLV's 15.46%, limiting the diversification benefit of holding both.

Seeking Alpha • a day ago

Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?

Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the Invesco S&P 500 Equal Weight Health Care ETF (RSPH), a passively managed exchange traded fund launched on November 1, 2006.

Zacks Investment Research • Aug 4, 2026

IXJ vs. RSPH: Which Healthcare ETF Is the Better Buy?

IXUS offers greater diversification with 110 holdings compared to 60 for RSPH. IXUS provides a significantly higher dividend yield than RSPH.

The Motley Fool • Jul 21, 2026

Healthcare Investing in 2026: iShares Global Healthcare ETF Outperforms Invesco Health Care ETF

iShares Global Healthcare ETF offers a higher dividend yield and lower volatility than Invesco S&P 500 Equal Weight Health Care ETF. Invesco S&P 500 Equal Weight Health Care ETF assigns identical weights to U.S. healthcare giants, while iShares Global Healthcare ETF weights its global holdings by market capitalization.

The Motley Fool • Jul 16, 2026

Invesco Healthcare ETF vs VanEck Biotech: Which ETF Will Deliver the Healthiest Returns for 2026?

Invesco S&P 500 Equal Weight Health Care ETF provides broader exposure with 60 holdings compared to the 25 positions in VanEck Biotech ETF VanEck Biotech ETF has a slightly lower expense ratio of 0.35% while Invesco S&P 500 Equal Weight Health Care ETF charges 0.40% Invesco S&P 500 Equal Weight Health Care ETF has experienced a significantly lower five-year maximum drawdown than the biotech fund

The Motley Fool • Jul 14, 2026

Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?

A smart beta exchange traded fund, the Invesco S&P 500 Equal Weight Health Care ETF (RSPH) debuted on 11/01/2006, and offers broad exposure to the Health Care ETFs category of the market.

Zacks Investment Research • Jun 26, 2026

Invesco's RSPH vs. PJP: Which Health Care ETF Is the Better Fund For The GLP-1 Revolution?

Invesco Pharmaceuticals ETF provides concentrated exposure to 29 drug manufacturers, while Invesco S&P 500 Equal Weight Health Care ETF offers equal-weighted access to 59 healthcare stocks Invesco S&P 500 Equal Weight Health Care ETF is more cost-efficient with a 0.40% expense ratio compared to 0.57% for Invesco Pharmaceuticals ETF Invesco Pharmaceuticals ETF has achieved higher total returns over both 1-year and 5-year periods with lower overall price volatility as measured by beta

The Motley Fool • Jun 15, 2026

Medical Technology Stocks: Innovation Endures As Valuations Reset

Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.

Seeking Alpha • May 2, 2026

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Survey data underscored how the war in the Middle East has already had a material impact on economic growth around the world. Drilling down deeper, the data showed weaker growth trends were recorded across all major industries globally.

Seeking Alpha • Apr 12, 2026

Can Forgotten Biotech Break Out?

After a 50%+ run from lows last April through highs in mid-January, the Biotech group has been trending sideways over the last few months. Biotech hasn't garnered much attention lately, with all the coverage of the Iran War and the AI Doom trade that's been taking down software stocks even as AI infrastructure stocks continue to surge.

Seeking Alpha • Apr 11, 2026